Please join three brothers on a quest to discover a cure for ataxia, the worst disease you have NEVER heard of, by donating today.
Ataxia with Oculomotor Apraxia Type 2 (AOA2) is a rare neurological disease. For families, such as ours, who are affected by it, life is never the same. Unfortunately, AOA2 tends to begin in late adolescence, leaving kids unable to drive, walk, write, and handle their own basic daily needs. Common symptoms include balance problems, tremors, loss of motor skills, double vision, and muscle weakness.
We remain optimistic about the future, thanks to Brent Fogel, M.D., Ph.D. who is determined to find a cure. He is the only clinician-scientist in the world researching new ways to treat AOA2.
Dr. Brent Fogel is the Director of the UCLA Neurogenetics Clinic and a member of the UCLA Ataxia Center. He is leading a multi-year research study to develop a groundbreaking gene therapy that has the potential to stop the progression of this disease.
Your financial support is critical, as this research is only funded by philanthropic support.
Thank you for your generosity! Every dollar makes a difference.
To donate by check via USPS, please issue a check payable to The UCLA Foundation with note/memo stating it is to support the De Mint AOA2 Research Fund (62741C). Please mail the check to The UCLA Foundation, PO Box 7145, Pasadena, CA 91109-9903.
If you do not wish to receive further fundraising information from UCLA Health Sciences, please either call us at (855) 364-6945 or email us at email@example.com providing your name, address, phone number, email, and from which department you're requesting to be removed. Should this fund reach the campus minimum required for the establishment of an endowment or quasi-endowment, The UCLA Foundation reserves the right to convert this fund to an endowment or quasi-endowment. Please review UCLA and The UCLA Foundation’s Disclosure Statements for Prospective Donors and to learn more about how The UCLA Foundation invests and manages its endowments at www.uclafoundation.org/disclosures.